ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
09 Mar 2020 13:00

Why Is the Death Rate of COVID-19 Nearly 6x Higher in the U.S. Than in South Korea?

This insight includes two-part sections. First, we discuss why the death rates of COVID-19 are nearly 6x higher in the U.S. as compared to South...

Logo
367 Views
Share
09 Mar 2020 11:59

List of Korea Pair Trade Setups: Which Pair Not to Miss Out on a Day like This?

Below is the full list of the stocks for a pairs trading in Korea. The table shows the current sigma of each setup on a 20D MA (at 12:30 in Seoul...

Logo
288 Views
Share
09 Mar 2020 08:16

KT&G: Where There Is Smoke, There May Be Fire

Recent press in Korea has highlighted that the Financial Supervisory Service (FSS) investigation into alleged accounting fraud at KT&G...

Logo
271 Views
Share
28 Feb 2020 08:27

Samsung C&T & Electronics Price Coupling Issue Amid New 3-Yr Shareholder Return Policy

Samsung C&T unveiled a new shareholder return policy for the next three years, FY20~FY22. It said that it would give out 60~70% of the dividend...

Logo
334 Views
Share
25 Feb 2020 17:36

Korea - Shorts Increase on Samsung Common and Pref Shares

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 21 February...

Logo
267 Views
Share
x